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ABSTRACT
The long-term risks of uninephrectomy in the living-related kidney donors are of concern. We studied
the outcome in living-related allograft donors after donation who have been followed up at Princess
Margaret Hospital from 1980 to 1996 by comparing renal function, blood pressure and proteinuria.
Ninety-one allograft donors, aged from 19 to 59 years (mean 36.61 +7.63 years; 43 males and 48
females) were followed up for 1 to 17 years (mean 5.5 +2.5 years). After nephrectomy, serum
creatinine rose by 46.2% from baseline 81.3 +13.0 µmol/L to 118.9 +32.9 µmol/L at 3 months (p <
0.001). In 58 of the 91 patients who were followed up for more than 3 years, serum creatinine
decreased to 99.7 +13.2 µmol/L (p < 0.05) at the end of the study period as compared with serum
creatinine at 3-month follow-up. Creatinine clearance also decreased from 107.6 +24.0 ml/min
before nephrectomy to 78.8 +15.7 ml/min at 1-year follow-up (p < 0.001). Then it became 79.8
+18.3 ml/min at the latest follow-up (p = 0.599). Systolic blood pressure increased from 114.2 +8.6
mmHg before nephrectomy to 120.0 +10.4 mmHg (p < 0.001) at the latest follow-up after
nephrectomy. Meanwhile, the diastolic blood pressure rose from 71.1 +7.2 mmHg at baseline to
73.1 +8.3 mmHg at the end of the study period (p = 0.091). The mean arterial blood pressure
increased from 85.5 +7.0 mmHg to 88.7 +8.1 mmHg at the latest follow-up (p<0.005). Proteinuria
increased from 65 +55 mg/day to 96 +55 mg/day at the latest follow-up (p = 0.142).
In conclusion, there was no progression of renal dysfunction in renal allograft donor after
nephrectomy. Serum creatinine even improved significantly at the end of the study period as
compared with that at 3-month postnephrectomy. Systolic blood pressure and mean arterial blood
pressure had a small increment at the latest follow-up. The prevalence of hypertension was 4.4%.
Moreover, proteinuria did not show a significant increase after donation.
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INTRODUCTION
In Hong Kong, 1,000 patients with end-stage renal
disease were in the waiting list for renal transplantation
in 1998. Thirty-three patients underwent cadaveric renal
transplant in the same year. The scarce supply of
cadaveric kidneys for transplant cannot meet the demand.
A growing shortage of cadaveric organs available for
renal transplantation has been accompanied by an
increased use of living donors. Data from the Hong Kong
Renal Registry showed that the number of living-related
renal transplants increased from 28 (32.6% of the total)
to 37 (52.9% of the total) from 1996 to 1998. There is an
increasing trend in the use of living donors for transplant.
Moreover, the long-term graft survival of living-related
renal transplant is better as compared with cadaveric
transplant (1). The advantages to the recipient of living-
related kidney transplantation have to be weighted
against the risk to the donor. Concerns have been
expressed about the long-term consequences of kidney
donation. Animal models have shown that excessive
reduction of renal mass leads to progressive renal
insufficiency and glomerular sclerosis in remnant kidney
tissue as a result of hyperfiltration of the remnant
nephrons. In rats, reduction of the number of functioning
nephrons results in hypertension, proteinuria and
progressive destruction of nephrons (2-3). In humans,
uninephrectomy of renal allograft donors is followed by
early compensatory changes. The glomerular filtration
rate and renal blood flow increase to about 70% of
prenephrectomy values within 7 days after donation (4).
Does this compensatory hyperfiltration in human lead
to renal insufficiency ultimately with longer duration of
follow-up? Isolated cases of renal failure after donor
nephrectomy have been reported. However, no large
series has demonstrated progressive deterioration of renal
function (5). Meta-analysis of investigations that
examined the long-term effects of reduced renal mass in
humans showed that uninephrectomy did not cause
progressive renal dysfunction, but might be associated
with a small increase in blood pressure (6). The long-
term risks of renal allograft donors are of concern.
PURPOSE OF STUDY
To examine whether uninephrectomy may lead to
progressive changes in renal function, hypertension and
proteinuria in living-related renal allograft donors.
PATIENTS AND METHODS
Between 1980 to 1996, 104 living-related donor
nephrectomies have been performed in Princess Margaret
Hospital. Out of these, 91 donors, aged from 19 to 59
years (mean age 36.6 +7.6 years; 43 males and 48
females) were followed up regularly in our clinic. The
mean donor age at nephrectomy was 31.1 +7.2 years.
The mean follow-up period was 5.5 +2.5 years (ranging
from 1-17 years). Clinical and biochemical parameters
including blood pressure and serum creatinine were
checked during renal transplant work-up and at 3-month,
6-month, and 1-year postnephrectomy, and then yearly.
Blood pressure was measured using a mercury
sphygmomanometer with the diastolic pressure taken as
Korotkoff phase 5. Mean arterial blood pressure was
calculated as the diastolic blood pressure plus one-third
of the pulse pressure. Glomerular filtration rate (GFR)
was assessed by saving 24 hours urine for creatinine
clearance preoperatively and at 3-month, 1-year and then
yearly. Before 1995, 24-hour urinary protein excretion
was measured by COBAS-BIO, using the turbidimetric
method of sulphasalicylic acid. After July 1995, it was
measured by DMA microprotein reagent adapted to the
Beckman CX5 analyzer. The data were presented as mean
+
 standard deviation (SD) and were compared using
student’s t test.
RESULTS
Serum Creatinine
The baseline serum creatinine was 81.3 +13.0 µmol/L.
After nephrectomy, serum creatinine rose by 46.2% to
118.9 +32.9 µmol/L at 3-month follow-up (p < 0.001).
Afterward, serum creatinine decreased to 106.2 +18.9
µmol/L at 1-year and 101.8 +15 µmol/L at 3-year follow-
up (p = 0.599 and p = 0.119, respectively, as compared
with serum creatinine at 3-month). In 58 of the 91 patients
who had follow-up for more than 3 years, serum
creatinine decreased by 16% to 99.7 +13.2 µmol/L (p <
0.05) at the end of the study period as compared with
creatinine checked at 3-month (Fig. 1).
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Glomerular Filtration Rate
GFR was measured using creatinine clearance. The
baseline creatinine clearance was 107.6 +4.0 ml/min.
After nephrectomy, it  decreased by 26.8% of
prenephrectomy level to 78.8 +5.7 ml/min at 1-year
follow-up (p < 0.001). With longer duration of follow-
up, creatinine clearance remained stable at 79.8 +18.3
ml/min at the latest follow-up as compared with
postnephrectomy level at 1-year (p = 0.599) (Table 1).
Blood pressure
The baseline systolic blood pressure was 114.2 +8.6
mmHg. After nephrectomy, it increased to 116.7 +10.3
mmHg at 1-year follow-up (p = 0.112) and 120.0 +10.4
mmHg (p < 0.001) at the latest follow-up respectively
(Table 1).
The diastolic blood pressure increased from baseline 71.1
+7.2 mmHg to 72.4 +5.8 mmHg at 1-year follow-up (p
= 0.177). It further rose to 73.1 +8.3 mmHg at the end of
the study period (p = 0.091) (Table 1). This increase was,
however, not statistically significant.
The baseline mean arterial pressure was 85.5 +7.0
mmHg. It rose to 87.2 +6.4 mmHg at 1-year after
nephrectomy (p = 0.079) and 88.7 +8.1 mmHg at the
end of the study period respectively (p < 0.005) (Table
1). Four donors (4.4%) became hypertensive during the
follow-up period. All were normotensive preoperatively.
Proteinuria
The baseline 24-hour urinary protein excretion was 65
+55 mg/day. It increased to 78 +50 mg/day (p = 0.247)
at 1-year follow-up and 96 +55 mg/day at the latest
follow-up (p = 0.142) respectively (Table 1).
DISCUSSION
This study showed that in renal allograft donors, serum
creatinine at 3-month postnephrectomy increased
significantly by 46.2% as compared with the preoperative
level. However, after 3 months there was a gradual
improvement of serum creatinine, which was sustained
throughout the rest of the follow-up period. The serum
creatinine level decreased by 16% from 118.9 +32.9
µmol/L at 3-month postnephrectomy to 99.7 +13.2 µmol/
L (p < 0.05) at the end of the study period. The creatinine
clearance declined slightly 3 months postoperatively but
it showed a similar trend of improvement throughout the
rest of the study period. There is no progressive
deterioration of the renal function observed in our study,
which is similar to the findings in other studies (6-9). In
a meta-analysis of investigations that examined the long-
term effects of reduced human renal mass in 2913
patients, it showed that unilateral nephrectomy caused a
17.1 ml/min decrement in glomerular filtration rate that
improved with each 10 years of follow-up at a rate of
1.4 ml/min/decade (6).
Concerning about the blood pressure changes, our study
showed that there was a small but significant increment
in systolic blood pressure and mean arterial blood
pressure but not in diastolic blood pressure with follow-
up. Kasiske et al also reported a 2.4 mmHg increase in
systolic blood pressure that rose further with duration of
follow-up at a rate of 1.1 mmHg/decade. However,
diastolic blood pressure did not change. He also showed
that nephrectomy did not affect the prevalence of
hypertension (6). The prevalence of hypertension was
4.4% in our study. The donor age of these four patients
at nephrectomy was 49, 43, 43 and 42 years which was
higher than the mean donor age of 31.1 +7.2 years. As
blood pressure goes up with age in the normal population,
Table 1. Levels of creatinine clearance (CCr), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial blood pressure
(MAP) and proteinuria of renal allograft donors before and after nephrectomy at the first year and the latest follow-up period.
Data (A)Baseline n = 91 (B)Postnephrectomy 1 year P value (C)Postnephrectomy latest FU P value
   A vs B  A vs C
  Ccr (ml/min) 107.6 +24 78.8 +15.7 < 0.001 79.8 +18.3 < 0.001
SBP (mmHg) 114.2 +8.6 116.7 +10.3 0.112 120.0 +10.4 < 0.001
DBP (mmHg) 71.1 +7.2 72.4 +5.8 0.177 73.1 +8.3 0.091
MAP (mmHg) 85.5 +7.0 87.2 +6.4 0.079 88.7 +8.1 < 0.005
Proteinuria (mg/day) 65 +55 78 +50 0.247 96 +55 0.142
Figure 1. The serial changes of serum creatinine level of renal
allograft donors after nephrectomy.
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donor age is an important factor in determining the final
blood pressure. It has been shown that donor age and
blood pressure at donation are independent predictors
of hypertension in subsequent follow-up (6). Other
studies showed that 4% to 31% of donors were
hypertensive at follow-up after nephrectomy (11). The
marked difference in the prevalence of hypertension after
nephrectomy is probably due to different selection criteria
for organ donation. Some workers accept donors with
hypertension for organ donation. In view of the finding
that a reduction in renal mass in humans causes a small
increase in blood pressure, it is reasonable to exclude
potential donors with hypertension. However, there are
centers that consider a donor with borderline
hypertension to be acceptable.
Proteinuria as an indicator of renal injury is another
parameter for assessment. Our study showed that there
was a small increase in proteinuria during follow-up,
which, however, did not reach statistical significance.
Meta-analysis of 1230 patients with nephrectomy by
Kasiske et al has shown that there was a small increase
in proteinuria over time after a 50% reduction in renal
mass (6). However, this increase in proteinuria is not
seen in patients who have reduced renal mass due to
organ donation or trauma. It may have been due to
underlying renal damage caused by cancer, infection,
unilateral agenesis and obstructive uropathy. Both the
amount and prevalence of proteinuria after kidney
donation do not increase with duration of follow-up.
Thus, there is no evidence that organ donation leads to
progressive renal injury manifested by proteinuria (6).
In summary, there is little long-term risk associated with
kidney donation. Potential renal allograft donor should
be reassured of the very small chance of deterioration of
renal function as a result of kidney donation. However,
there may be a small increase in blood pressure after
nephrectomy. The donor age and blood pressure at
donation are independent predictors of hypertension.
Hence it is reasonable to exclude donors with
hypertension for donation. There is controversy over the
issue of potential donor with borderline hypertension for
donation. A registry of long-term follow-up data from
renal allograft donors involving multicenters might
clarify this controversy in future.
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